English TOP > Research achievements

Address

Laboratory of Neuroscience
Department of Biology,
Faculty of Science,
Toho University

2-2-1 Miyama, Funabashi,
Chiba, 274-8510 Japan

Research achievements

 

Thesis

Bachelor of Science (department of Biology, Faculty of Science, Toho University, March 1983)
“Mechanisms of the effect of the psychostimulant in hyperkinetic-child model rats.”

Master of Medical Science (Master program, graduate school of medical science, University of Tsukuba, March 1986)“
Biochemical study on the plasticity in the basal ganglia: temporal changes in the content of neurotransmitters after unilateral striatal lesion.”

PhD in Neurosciences (Doctor program, graduate school, University of Paris 6, June 1990)
“Neurotensin systems in the rat striatum and substantia nigra. Effects of cerebral lesions on neurotensin content and its binding site density.”

PhD in Medicine (Faculty of Medicine, University of Tokyo, July 1994)
“Studies on pituitary adenylate cyclase-activating polypeptide (PACAP) in the rat central nervous system.”

Publication

English

  1. Hori M, Kubo H, Shibato J, Saito T, Ogawa T, Wakamori M, Masuo Y, Shioda S, Rakwal R. Unraveling the rat blood genome-wide transcriptome after oral administration of Lavender oil by a two-color dye-swap DNA microarray approach. Genomics Data. 8 (2016) 139-145.
  2. Kobayashi Y, Kulikova SP, Shibato J, Rakwal R, Satoh H, Pinault D, Masuo Y. DNA microarray unravels rapid changes in transcriptome of MK-801 treated rat brain. World J Biol Chem. 6 (2015) 389-408.
  3. Kasuya H, Okada N, Kubohara M, Satou T, Masuo Y, Koike K. Expression of BDNF and TH mRNA in the brain following inhaled administration of α-pinene. Phytother Res. 29 (2015) 43-47.
  4. Ishido M, Masuo Y, Temporal effects of bisphenol A on dopaminergic neurons: an experiment on adult rats. Open Environmental Sciences. 8 (2014) 9-17.
  5. Kasuya H, Hata E, Satou T, Yoshikawa M, Hayashi S, Masuo Y, Koike K. Effect on emotional behavior and stress by inhalation of the essential oil from Chamaecyparis obtusa. Nat Prod Commun. 8 (2013) 515-518.
  6. Takahashi M, Yoshino A, Yamanaka A, Asanuma C, Satou T, Hayashi S, Masuo Y, Sadamoto K, Koike K, Effects of inhaled lavender essential oil on stress-loaded animals: changes in anxiety-related behavior and expression levels of selected mRNAs and proteins. Nat Prod Commun. 7 (2012) 1539-1544.
  7. Miyagawa R, Tano K, Mizuno R, Nakamura Y, Ijiri K, Rakwal R, Shibato J, Masuo Y, Mayeda A, Hirose T, Akimitsu N, Identification of cis- and trans-acting factors involved in the localization of MALAT-1 noncoding RNA to nuclear speckles. RNA. 18 (2012) 738-751.
  8. Ishido M, Masuo Y, Terasaki M, Morita M, Rat hyperactivity by bisphenol A, but not by its derivatives, 3-hydroxybisphenol A or bisphenol A 3,4-quinone. Toxicol Lett. 206 (2011) 300-305.
  9. Tano K, Mizuno R, Okada T, Rakwal R, Shibato J, Masuo Y, Ijiri K, Akimitsu N, MALAT-1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility-related genes. FEBS Lett. 584 (2010) 4575-4580.
  10. Akazawa YO, Saito Y, Hamakubo T, Masuo Y, Yoshida Y, Nishio K, Shichiri M, Miyasaka T, Iwanari H, Mochizuki Y, Kodama T, Noguchi N, Niki E, Elevation of oxidized DJ-1 in the brain and erythrocytes of Parkinson disease model animals. Neurosci Lett. 483 (2010) 201–205.
  11. Tano K, Hamamoto H, Ito T, Sumiya E, Rakwal R, Shibato J, Masuo Y, Ijiri K, Sekimizu K, Akimitsu N. Reduced expression of Sytl 1 and Ccdc21 and impaired induction of Mt I by oxidative stress in SII-K1 knockout mice. Drug Discov Ther. 4 (2010) 368-72.
  12. Akazawa YO, Saito Y, Nishio K, Horie M, Kinumi T, Masuo Y, Yoshida Y, Ashida H, Niki E, Proteomic characterization of the striatum and midbrain treated with 6-hydroxydopamine: alteration of 58-kDa glucose-regulated protein and C/EBP homologous protein. Free Radic Res. 44 (2010) 410-421.
  13. Jang S, Cho K, Shibato J, Han O, Iwahashi H, Tamogami S, Zargar SM, Kubo A, Masuo Y, Agrawal GK, Rakwal R. Rice OsOPRs: Transcriptional Profiling Responses to Diverse Environmental Stimuli and Biochemical Analysis of OsOPR1. Journal of Plant Biology. 52 (2009) 229-243.
  14. Masuo Y, Imai T, Shibato J, Hirano M, Jones OAH, Maguire ML, Satoh K, Kikuchi S, Rakwal R. Omic analyses unravels global molecular changes in the brain and liver of a rat model for chronic Sake (Japanese alcoholic beverage) intake. Electrophoresis. 30 (2009) 1259–1275.
  15. Rakwal R, Agrawal GK, Shibato J, Imanaka T, Fukutani S, Tamogami S, Endo S, Sahoo SK, Masuo Y, Kimura S. Ultra low-dose radiation: stress responses and impacts using rice as a grass model. Int J Mol Sci. 10 (2009) 1215-1225.
  16. Hirano M, Shibato J, Rakwal R, Kouyama N, Katayama Y, Hayashi M, Masuo Y. Transcriptomic analysis of rat brain tissue following gamma knife surgery: early and distinct bilateral effects in the un-irradiated striatum. Mol Cells. 27 (2009) 263-268.
  17. Kim du H, Shibato J, Kim DW, Oh MK, Kim MK, Shim IeS, Iwahashi H, Masuo Y, Rakwal R. Gel-based proteomics approach for detecting low nitrogen-responsive proteins in cultivated rice species. Physiol Mol Biol Plants. 15 (2009) 31-41.
  18. Deepak SA, Shibato J, Ishii H, Ogawa Y, Yoshida Y, Iwahashi H, Masuo, Y, Agrawal GK, Rakwal R. Proteomics approach for investigating the disease resistance using cucumber as model plant. Am J Biochem Biotech. 4 (2008) 231-238.
  19. Furusawa T, Rakwal R, Nam HW, Shibato J, Kim YS, Ogawa Y, Yoshida Y, Masuo Y, Kouzuma Y, Agrawal GK, Yonekura M. Comprehensive ryal jelly (RJ) proteomics using one- and two-dimensional proteomics platforms reveals novel RJ proteins and phospho/glycoproteins. J Proteome Res. 7 (2008) 3194-3229.
  20. Seo HS, Hirano M, Shibato J, Rakwal R, Hwang IK, Masuo Y. Effects of coffee bean aroma on the rat brain stressed by sleep deprivation: a selected transcript- and 2D gel-based proteome analysis. J Agric Food Chem. 56 (2008) 4665-4673.
  21. Cho K, Shibato J, Agrawal GK, Jung YH, Kubo A, Jwa NS, Tamogami S, Satoh K, Kikuchi S, Higashi T, Kimura S, Saji H, Tanaka Y, Iwahashi H, Masuo Y, Rakwal R. Integrated transcriptomics, proteomics and metabolomics analyses to survey ozone responses in the leaves of rice seedling. J Proteome Res. 7 (2008) 2980-2998.
  22. Hirano M, Rakwal R, Shibato J, Sawa H, Nagashima K, Ogawa Y, Yoshida Y, Iwahashi H, Niki E, Masuo Y. Proteomics- and transcriptomics-based screening of differentially expressed proteins and genes in brain of Wig rat: a model for attention-deficit hyperactivity disorder (ADHD) research. J Proteome Res. 7 (2008) 2471-2489.
  23. Horie K, Rakwal R, Hirano M, Shibato J, Nam HW, Kim YS, Kouzuma Y, Agrawal GK, Masuo Y, Yonekura M. Proteomics of two cultivated mushrooms Sparassis crispa and Hericium erinaceum provides insight into their numerous functional protein components and diversity. J Proteome Res. 7 (2008) 1819-1835.
  24. Torres NL, Cho K, Shibato J, Hirano M, Kubo A, Masuo Y, Iwahashi H, Jwa NS, Agrawal GK, Rakwal R. Gel-based proteomics reveals potential novel protein markers of ozone stress in leaves of cultivated bean and maize species of Panama. Electrophoresis. 28 (2007) 4369-4381.
  25. Hirano M, Rakwal R, Kouyama N, Katayama Y, Hayashi M, Shibato J, Ogawa Y, Yoshida Y, Iwahashi H, Masuo Y. Gel-based proteomics of unilateral irradiated striatum after gamma knife surgery. J Proteome Res. 6 (2007) 2656-2668.
  26. Masuo Y, Ishido M, Morita M, Sawa H, Nagashima K, Oka S, Niki E. Behavioural characteristics and gene expression in the hyperactive wiggling (Wig) rat. Eur J Neurosci. 25 (2007) 3659-3666.
  27. Deepak SA, Kottapalli KR, Rakwal R, Oros G, Rangappa KS, Iwahashi H, Masuo Y, Agrawal GK. Real-time PCR: revolutionizing detection and expression analysis of genes. Current Genomics. 8 (2007) 234-251.
  28. Masuo Y, Ogura A, Kobayashi M, Masaki T, Furuta Y, Ono T, Takamatsu K. Hippocalcin protects hippocampal neurons against excitotoxin damage by enhancing calcium extrusion. Neuroscience. 145 (2007) 495-504.
  29. Saito Y, Nishio K, Ogawa Y, Kinumi T, Yoshida Y, Masuo Y, Niki E. Molecular mechanisms of 6-hydroxydopamine-induced cytotoxicity in PC12 cells – Involvement of hydrogen peroxide-dependent and –independent action. Free Radical Bio Med. 42 (2007) 675-685.
  30. Hirano M, Rakwal R, Shibato J, Agrawal GK, Jwa NS, Iwahashi H, Masuo Y. New protein extracton/slubilization protocol for gel-based proteomics of rat (female) whole brain and brain regions. Mol Cells. 22 (2006) 119-125.
  31. Itoh N, Masuo Y, Yoshida Y, Cynshi O, Jishage KI, Niki E. g-Tocopherol attenuates MPTP-induced dopamine loss more efficiently than a-tocopherol in mouse brain. Neurosci Lett. 403 (2006) 136-140.
  32. Ishikawa Y, Kozakai T, Morita H, Saida K, Oka S, Masuo Y. Rapid detection of Mycoplasma contamination in cell cultures using syber green-based real-time polymerase chain reaction. In Vitro Cell Dev Biol Anim. 42 (2006) 63-69.
  33. Kobayashi M, Masaki T, Hori K, Masuo Y, Miyamoto M, Tsubokawa H, Noguchi H, Nomura M, Takamatsu K. Hippocalcin-deficient mice display a deficit in cAMP response element-binding protein activation associated with impaired special and associative memory. Neuroscience. 133 (2005) 471-484.
  34. Hanai S, Masuo Y, Shirai H, Oishi K, Saida K, Ishida N. Differential circadian expression of endothelin-1 mRNA in the rat suprachiasmatic nucleus and peripheral tissues. Neurosci Lett. 377 (2005) 65-68.
  35. Ishido M, Morita M, Oka S, Masuo Y. Alteration of gene expression of G protein-coupled receptors in endocrine disruptors-caused hyperactive rats. Regul Peptides. 126 (2005) 145-153.
  36. Ishido M, Masuo Y. Transcriptome of pituitary adenylate cyclase-activating polypeptide-differentiated PC12 cells. Regul Peptides. 123 (2004) 15-21.
  37. Masuo Y, Morita M, Oka S, Ishido M. Motor hyperactivity caused by a deficit in dopaminergic neurons and the effects of endocrine disruptors: a study inspired by the physiological roles of PACAP in the brain. Regul Peptides. 123 (2004) 225-234.
  38. Masuo Y, Ishido M, Morita M, Oka S, Niki E. Motor activity and gene expression in rats with neonatal 6-hydroxydopamine lesions. J Neurochem. 91 (2004) 9-19.
  39. Ishido M, Masuo Y, Oka S, Morita M. Dicyclohexylphthalate causes hyperactivity in the rat concomitantly with impairment of tyrosine hydroxylase immunoreactivity. J Neurochem. 91 (2004) 69-76.
  40. Ishido M, Masuo Y, Oka S, Niki E, Morita M. p-Nitrotoluene causes hyperactivity in the rat. Neurosci Lett. 366 (2004) 1-5.
  41. Ishido M, Masuo Y, Oka S, Kunimoto M, Morita M. Bisphenol A causes hyperactivity in the rat concomitantly with impairment of tyrosine hydroxylase immunoreactivity, J Neurosci Res. 76 (2004) 423-433.
  42. Ishido M, Masuo Y, Oka S, Niki E, Morita M. Intracisternal administration of p-n-octylphenol into neonatal rats causes hyperactivity concomitantly with the terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL)-positive cells in the mesencephalon where immunoreactivity for tyrosine hydroxylase is reduced by the chemical. J Health Sci. 50 (2004) 407-412.
  43. Masuo Y, Ishido M, Morita M, Oka S. Effects of neonatal treatment with 6-hydroxydopamine and endocrine disruptors on motor activity and gene expression in rats. Neural Plast. 11 (2004) 59-76.
  44. Masuo Y, Ishikawa Y, Kozakai T, Uchide T, Komatsu Y, Saida K. Vasoactive intestinal contractor/endothelin-2 gene expression in the murine central nervous system. Biochem Biophys Res Commun. 300 (2003) 661-668.
  45. Masuo Y, Ishido M, Morita M, Oka S. Effects of neonatal 6-hydroxydopamine lesion on the gene expression profile in young adult rats. Neurosci Lett. 335 (2002) 124-128.
  46. Kozakai T, Sakate M, Masuo Y, Uchide T, Saida K. Increased gene expression of endothelin-1 and vasoactive intestinal contractor/endothelin-2 in the mammary gland of lactating mice. Biochem Biophys Res Commun. 297 (2002) 1339-1343.
  47. Kozakai T, Hong Z, Sakate M, Masuo Y, Uchide T, Saida K. Effects of aging and ethanol-induced gastric mucosal injury on gene expression rates of ET-1 and ET-2/VIC in the mouse stomach. Clin Sci. 103, Suppl 48 (2002) 455S-458S.
  48. Uchide T, Fujimori Y, Sasaki T, Temma K, Masuo Y, Kozakai T, Saida K. Expression of endothelin-1 and vasoactive intestinal contractor genes in mouse organs during the perinatal period. Clin Sci. 103, Suppl 48 (2002) 167S-170S.
  49. Ishido M, Masuo Y, Oka S, Kunimoto M, Morita M. Application of Supermex system to screen behavioral traits produced by tributyltin in the rat. J Health Sci. 48 (2002) 451-454.
  50. Hinuma S, Habata Y, Fujii R, Kawamata Y, Hosoya M, Fukusumi S, Kitada C, Masuo Y, Asano T, Matsumoto H, Sekiguchi M, Kurokawa T, Nishimura O, Onda H, Fujino M. A prolactin-releasing peptide in the brain. Nature. 393 (1998) 272-276.
  51. Fukuhara C, Inouye SI, Matsumoto Y, Tsujimoto G, Aoki K, Masuo Y. Pituitary adenylate cyclase-activating polypeptide (PACAP) rhythm in the rat pineal gland. Neurosci Lett. 241 (1998) 115-118.
  52. Masuo Y, Matsumoto Y, Morita S, Noguchi J. A novel method for counting spontaneous motor activity in the rat. Brain Res Protoc. 1 (1997) 321-326.
  53. Fukuhara C, Suzuki N, Matsumoto Y, Nakayama Y, Aoki K, Tsujimoto G, Inouye S-I, Masuo Y. Day-night variation of pituitary adenylate cyclase-activating polypeptide (PACAP) level in the rat suprachiasmatic nucleus. Neurosci Lett. 229 (1997) 49-52.
  54. Hosoya M, Fujii R, Fukusumi S, Ohtaki T, Nagai H, Masuo Y, Miyazaki J, Onda H, Hinuma S. Molecular cloning and characterization of a mouse galanin receptor derived from a pancreatic beta cell line, MIN6: structure of cDNA, tissue distribution, and chromosomal localization. Takeda Research Report. Report No. 12897 (1995).
  55. Nicot A, Bidard JN, Kitabgi P, Lhiaubet AM, Masuo Y, Palkovits M, Rostène W, Berod A. Neurotensin and neuromedin N brain levels after fornix transection: evidence for an efficient neurotensin precursor processing in subicular neurons. Brain Res. 702 (1995) 279-283.
  56. Masuo Y, Noguchi J, Morita S, Matsumoto Y. Effects of intracerebroventricular administration of pituitary adenylate cyclase-activating polypeptide (PACAP) on the motor activity and reserpine-induced hypothermia in murines. Brain Res. 700 (1995) 219-226.
  57. Masuo Y, Tokito F, Matsumoto Y, Shimamoto N, Fujino M. Ontogeny of pituitary adenylate cyclase activating polypeptide (PACAP) and its binding sites in the rat brain. Neurosci Lett. 170 (1994) 43-46.
  58. Ogi K, Miyamoto Y, Masuda Y, Habata Y, Hosoya M, Ohtaki T, Masuo Y, Onda H, Fujino M. Molecular cloning and functional expression of a cDNA encoding a human pituitary adenylate cyclase activating polypeptide (PACAP) receptor. Biochem Biophys Res Commun. 196 (1993) 1511-1521.
  59. Checler F, Barelli H, Dauch P, Vincent B, Dive V, Beaudet A, Daniel EE, Fox-Threlkeld JET, Masuo Y, Vincent JP. Recent advances on endopeptidase-3.4.24.16. Biochemical Society Transactions. 21 (1993) 692-697.
  60. Dauch P, Masuo Y, Vincent JP, Checler F. A survey of the cerebral regionalization and ontogeny of eight exo- and endo-peptidases in murines. Peptides. 14 (1993) 593-599.
  61. Masuo Y, Matsumoto Y, Tokito F, Tsuda M, Fujino M. Effects of vasoactive intestinal polypeptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) on the spontaneous release of acetylcholine from the rat hippocampus by microdialysis. Brain Res. 611 (1993) 207-215.
  62. Masuo Y, Suzuki N, Matsumoto H, Tokito F, Matsumoto Y, Tsuda M, Fujino M. Regional distribution of pituitary adenylate cyclase activating polypeptide (PACAP) in the rat central nervous system as determined by sandwich-enzyme immunoassay. Brain Res. 602 (1993) 57-63.
  63. Kitada C, Ohtaki T, Masuda Y, Masuo Y, Nomura H, Asami T, Matsumoto Y, Satou M, Fujino M. Design and synthesis of ETA receptor antagonists and study of ETA receptor distribution. J Cardiovascular Pharmacol. 22 Suppl. 8 (1993) S128-S131.
  64. Dauch P, Masuo Y, Vincent JP, Checler F. Endopeptidase 24.16 in murines: tissue distribution, cerebral regionalization and ontogeny. J Neurochem. 59 (1992) 1862-1867.
  65. Checler F, Dauch P, Masuo Y, Vincent JP. Neurotensin and neuromedin N undergo distinct proteolytic inactivation in ventral tegmental area and nucleus accumbens. Ann NY Acad Sci. 668 (1992) 329-332.
  66. Rostène W, Brouard A, Dana C, Masuo Y, Agid F, Vial M, Lhiaubet AM, Pélaprat D. Interaction between neurotensin and dopamine in the brain. Morphofunctional and clinical evidence. Ann NY Acad Sci. 668 (1992) 217-231.
  67. Masuo Y, Wong H, Pélaprat D, Chi ZQ, Rostène W. Effect of brain lesions on [3H]ohmefentanyl binding site densities in the rat striatum and substantia nigra. Chem Pharm Bull. 40 (1992) 2520-2524.
  68. Masuo Y, Ohtaki T, Masuda Y, Tsuda M, Fujino M. Binding sites for pituitary adenylate cyclase activating polypeptide (PACAP): comparison with vasoactive intestinal polypeptide (VIP) binding site localization in rat brain sections. Brain Res. 575 (1992) 113-123.
  69. Watanabe T, Masuo Y, Matsumoto H, Suzuki N, Ohtaki T, Masuda Y, Kitada C, Tsuda M, Fujino M. Pituitary adenylate cyclase activating polypeptide provokes cultured rat chromaffin cells to secrete adrenaline. Biochem Biophys Res Commun. 182 (1992) 403-411.
  70. Kitabgi P, De Nadai F, Labbe-Jullie C, Dubuc I, Nouel D, Costentin J, Masuo Y, Rostène W, Woulfe J, Lafortune L, Beaudet A, Fulcrand H, Doulut S, Rodriguez M, Martinez J. Functional and pharmacological aspects of central neuropeptidergic transmission mediated by neurotensin and neuromedin N. Clin Neuropharmacol. 15 Suppl. 1 (1992) Pt. A, 313A-314A.
  71. Masuo Y, Giscard-Dartevelle S, Bouizar Z, Rostène W. Effects of cerebral lesions on binding sites for calcitonin and calcitonin gene-related peptide in the rat nucleus accumbens and ventral tegmental area. J Chemical Neuroanatomy. 4 (1991) 249-257.
  72. Masuo Y, Ohtaki T, Masuda Y, Nagai Y, Suno M, Tsuda M, Fujino M. Autoradiographic distribution of pituitary adenylate cyclase activating polypeptide (PACAP) binding sites in the rat brain. Neurosci Lett. 126 (1991) 103-106.
  73. Checler F, Dauch P, Masuo Y, Vincent JP. Neurotensin and neuromedin N are differently metabolized in ventral tegmental area and nucleus accumbens. J Neurochem. 56 (1991) 1320-1328.
  74. Kitabgi P, Masuo Y, Nicot A, Berod A, Cuber JC, Rostène W. Marked variations of the relative distributions of neurotensin and neuromedin N in micropunched rat brain areas suggest differential processing of their common precursor. Neurosci Lett. 124 (1991) 9-12.
  75. Masuo Y, Pélaprat D, Scherman D, Rostène W. [3H]Dihydrotetrabenazine, a new marker for the visualization of dopaminergic denervation in the rat striatum. Neurosci Lett. 114 (1990) 45-50.
  76. Masuo Y, Montagne MN, Pélaprat D, Scherman D, Rostène W. Regulation of neurotensin-containing neurons in the rat striatum. Effects of unilateral striatal lesions with quinolinic acid and ibotenic acid on neurotensin content and its binding site density. Brain Res. 520 (1990) 6-13.
  77. Masuo Y, Pélaprat D, Montagne MN, Scherman D, Rostène W. Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density. Brain Res. 510 (1990) 203-210.
  78. Darchen F, Masuo Y, Vial M, Rostène W, Scherman D. Quantitative autoradiography of the rat brain vesicular monoamine transporter using the binding of [3H]dihydrotetrabenazine and 7-amino-8-[125I]iodoketanserin. Neuroscience. 33 (1989) 341-349.
  79. Masuo Y, Kanazawa I. Effects of the unilateral striatal lesion on neurotransmitter markers in the contralateral striatum and both substantia nigrae of the rat. Neuroscience. 27 (1988) 827-836.
  80. Taniguchi T, Fujiwara M, Masuo Y, Kanazawa I. Levels of neurokinin A, neurokinin B and substance P in rabbit iris sphincter muscle. Jpn J Pharmacol. 42 (1986) 590-593.

Japanese

  1. Masuo Y, Stress inhibiting effects by coffee bean aroma: alterations in the expression of genes and proteins in the brain. Aroma Research, 9 (2008) 54-61.
  2. Masuo Y, New viewpoints on environmental improvement and health enhancement. Jouirnal of Japan Society of Applied Science, 20 (2006) 40-41.
  3. Masuo Y, Possibility of development of symptoms of psychiatric/neurological disorders by environmental stress. Jouirnal of Japan Society of Applied Science, 20 (2006) 23-28.
  4. Saida K, Zhao H, Sravan KG, Makiyama Y, Mitsui Y, Oka S, Kosakai T, Sakade M, Ishikawa Y, Masuo Y, Maga J, Uchide T, Change in the expression and localization of the precursor gene of the vasoactive intestinal contractor (VIC)/endothelin-2 in the womb. Gastrointestinal hormone, 19 (2001) 68-73.
  5. Koyama K, Hama H, Masuo Y, Koyama K, Goto K, Effects of L-glufosinate and its metabolite on the rat behavior. Journal of Japanese Association for Acute Medicine, 7 (1996) 731-732.
  6. Masuo Y, Kanazawa I, Effects of unilateral lesion in the striatum on neurotransmitters in the basal ganglia. Neuropsychopharmacology, 7 (1985) 729-739. 

Review

  1. Masuo Y, Fatigue recovery with coffee bean aroma: alterations in the expression of genes and proteins, Aromatopia, 21 (2012) 26-29.
  2. Masuo Y, Ishido M, Neurotoxicity of endocrine disruptors: possible involvement in brain development and neurodegeneration, J Toxicol Environ Health B Crit Rev, 14 (2011) 346-369.
  3. Masuo Y, Ishodo M, Environmental hormone. in Environmental Substances and a Cellular Function, Special edition: neuron and environment/poisoning. Clinical Neuroscience, 25 (2007) 874-876.
  4. Masuo Y, Ishido M, How does material environment influence autism and attention-deficit hyperactivity disorder? Seishinka (psychiatry), 6 (2005) 245-251.
  5. Masuo Y, Hyperkinetic disorder and curative medicine. No to Kusuri (Brain and medicine), No 21 (Brain 21), 8 (2005) 80-85. 

Book

  1. Masuo, Y, Shibato J, Rakwal R, ADHD animal model Characterization : a Transcriptomics and Proteomics Analysis. In F.H. Kobeissy (Ed.), Psychiatric Disorders: Methods and Protocols, Methods in Molecular Biology, Springer (Humana Press), vol. 829, pp. 505-530.
  2. Masuo, Y, Hirano M, Shibato J, Nam HW, Fournier J, Celine M, Wisztorski M, Salzet M, Soya H, Agrawal GK, Ogawa T, Shioda S, Rakwal R, Brain proteomics: sampling preparation techniques for the analysis of rat brain samples using mass spectrometry. In A. Ivanov and A. Lazarev (Eds), Sample Preparation in Biological Mass Spectrometry, Springer (Humana Press), 2011, pp. 171-195.
  3. Kitagawa E, Kishi K, Ippongi T, Kawauchi H, Nakazono K, Suzuki K, Ohba H, Hayashi Y, Iwahashi H, Masuo Y. Effects of endocrine disruptors on nervous system related gene expression: comprehensive analysis of Medaka fish. In Y.J. Kim, U. Platt, M.B. Gu, H. Iwahashi (Eds), Atmospheric and Biological Environmental Monitoring, Springer (2009) 229-239.
  4. Masuo Y, Niki E, Stress and aging in the brain. In Maruyama Y (Ed. supervision), Stress and aging: Mental and Physical, 4th piece of ‘Aging control of the brain and biomarkers: basic research and food material’, CMC publishing, 2009, pp. 271-280.
  5. Masuo Y, Full-scale research towards industrial creation on mental health: development of symptoms of neuropsychiatric disorders by stress and its controlling method. Sansoken Today (AIST Today), Sansoken (National Institute of Industrial Science and Technology, AIST), vol 9 (3), 2009, pp. 14-15.
  6. Masuo Y, Stress and disorsers: the central nervous system. In Niki E. (Ed.), Stress science and health, Kyoritsu press, 2008, pp. 122-128.
  7. Iwahashi H, Rakwal R, Masuo Y, Tanaka Y, Higashi T, Wakida S, Studies on the development of technology for evaluation and prediction of environmental stress caused by chemical products using metabolomics. The Heisei 17 fiscal year "collection of results of studies for environmental preservation", Japanese Ministry of Environment, 2006, pp. 36-1 to 36-8.
  8. Masuo Y, Mental disorders by the stress: studies for constructing methods for scientific evaluation of stress. Powerful Kansai, Kansai, Bureau of Economy, Trade and Industry, 2006, 44, pp. 30-31.
  9. Masuo Y, Possibility of mental disorders caused by environmental chemicals: evaluation of chemicals which influence on the animal brain. AIST Today, AIST, 2004, vol 4 (12), 2004, pp. 24-24.
  10. Checler F, Dauch P, Barelli H, Dive V, Vincent B, Masuo Y, Vincent JP. Identification and distribution of endopeptidase 24.16 in the central nervous system. In A.I. Smith (Ed.), Methods in Neurosciences, Vol. 23, Peptidases and Neuropeptide Processing, Academic Press, 1995, pp. 363-382.
  11. Desnos C, Darchen F, Masuo Y, Rostène W, Scherman D. Dynamic properties of monoamine storage vesicles: pharmacological and physiological implications. In S.Z. Langer, A.M. Galzin and J. Costentin (Ed.), Advances in the Biosciences, Vol. 82, Presynaptic receptors and neuronal transporters, Pergamon Press, 1991, pp. 193-196. 

Conference

International meeting

  1. Suzuki K, Rakwal R, Shibato J, Masuo Y. From stress to depression. 11th World Congress of Biological Psychiatry (WFSBP Congress 2013), Kyoto, June 23-27, 2013.
  2. Masuo Y, Ishido M. Attention-deficit hyperactivity disorder (ADHD) and endocrine disruptors. 7th International Congress of Neuroendocrinology, Rouen, France, Jul. 11-15, 2010.
  3. Masuo Y, Ishido M. Neurotoxicity of endocrine disruptors: possible roles in the etiology of developmental and neurodegenerative disorders. Neuroendocrine effects of endocrine disrupters (NEED), Satellite symposium of the 7th International Congress of Neuroendocrinology, Rouen, France, Jul. 10, 2010.International Program Committee
  4. Masuo Y, Hirano M, Shibato J, Rakwal R, Novel stress markers for psychiatric and neurodegenerative disorders. NeuroTalk 2010, Singapore, Jun. 25-28, 2010.Program Committee
  5. Ogawa Y, Saito Y, Nishio K, Yoshida Y, Masuo Y, Ashida H, Niki E. Oxidative stress in the brain of ADHD model rats (animal model for attention-deficit hyperactivity disorder). Lipid peroxidation 2008, Nagano, Oct. 15-17, 2008.
  6. Masuo Y. Novel biomarker candidates for mental disorders and stress. Dresden University School of Medicine, Dresden, Oct. 6, 2008.
  7. Masuo Y, Hirano M, Shibato J, Rakwal R. Integrated 'OMIC' analyses of the rat brain: Novel biomarker candidates for mental disorders and stress. Ehrlich II – 2nd World Conference on Magic Bullets, Nürnberg, Oct. 3 - 5, 2008.
  8. Hirano M, Seo HS, Shibato J, Rakwal R, Hwang IK, Masuo Y. Effects of coffee bean aroma on the rat brain stressed by sleep deprivation. HSSRC/AIST-NIEHS/NIH Joint International Symposium on Biomarkers of Oxidative Stress in Health and Diseases (BOSHD) 2008, Osaka, Jan. 16-19, 2008.
  9. Rakwal R, Hirano M, Shibato J, Kouyama N, Katayama Y, Hayashi M, Iwahashi H, Masuo Y. Exploring the effects of gamma irradiation by proteomics and transcriptomics profiling in rat striata after gamma knife surgery. HSSRC/AIST-NIEHS/NIH Joint International Symposium on Biomarkers of Oxidative Stress in Health and Diseases (BOSHD) 2008, Osaka, Jan. 16-19, 2008.
  10. Masuo Y, Hirano M, Shibato J, Rakwal R. Transcriptomics and proteomics in animal models for attention-deficit hyperactivity disorder (ADHD). HSSRC/AIST-NIEHS/NIH Joint International Symposium on Biomarkers of Oxidative Stress in Health and Diseases (BOSHD) 2008, Osaka, Jan. 16-19, 2008.
  11. Hirano M, Rakwal R, Shibato J, Kouyama N, Hayashi M, Ogawa Y, Yoshida Y, Iwahashi H, Masuo Y. Proteomics and transcriptomics of unilateral irradiated and contralateral striata after gamma knife surgery. HUPO (Human Proteome Organization) 6th Annual World Congress (Oct. 6-10), Seoul, Korea, Oct. 9, 2007.
  12. Masuo Y, Hirano M, Shibato J, Sawa H, Nagashima K, Ogawa Y, Yoshida Y, Iwahashi H, Rakwal R. Proteomics- and transcriptomics-based screening of differentially expressed proteins and genes in the brain of Wig rat: a model for ADHD research. HUPO (Human Proteome Organization) 6th Annual World Congress (Oct. 6-10), Seoul, Korea, Oct. 8, 2007.
  13.  Masuo Y. The effects of environmental chemicals on the brain development. 13th International Symposium on Toxicity Assessment (Aug. 20-24, 2007), Toyama, Japan, Aug. 23, 2007.
  14. Hirano M, Kouyama N, Shibato J, Ogawa Y, Rakwal R, Yoshida Y, Iwahashi I, Masuo Y. Stress and the brain: proteomic analysis of rat striatum after gamma knife irradiation. AIST-KU (Korea University) Joint Symposium of Advances in Biosciences and Biotechnology, Tsukuba, Japan, Jan. 22, 2007.
  15. Saito Y, Nishio K, Ogawa Y, Kinumi T, Yoshida Y, Masuo Y, Niki E. Molecular mechanisms of 6-hydroxydopamine-induced neurotoxicity. SFRBM (Society for Free Radical Biology and Medicine)'s 13th Annual Meeting, Denver, Colorado, U.S.A., Nov. 15, 2006.
  16. Kitagawa E, Kishi K, Masuo Y, Iwahashi H, Ippongi T, Kawauchi H, Nakazono K, Inoue M, Ohba H, Hayashi Y. Comprehensive gene expression analysis of medaka fish: effects of endocrine disruptors on the nervous system. 3rd International Workshop on Biochips and Environmental Monitoring, Osaka, Japan, Aug. 17-18, 2006.
  17. Masuo Y. Transcriptome analysis in rat models for brain developmental disorders. 3rd International Workshop on Biochips and Environmental Monitoring, Osaka, Japan, Aug. 17-18, 2006.
  18. Masuo Y. Effects of environmental stress on the rat brain: comparison with animal models for developmental disorders, Seminar in the INSERM U339, Hôpital Saint-Antoine, Paris, France, Mar. 3, 2006.
  19. Masuo Y. Effects of environmental stress on the rat brain: comparison with animal models for developmental disorders. Seminar in the INSERM U676 & Service de Neuropediatrie, Hôpital Robert Debre, Paris, France, Mar. 2, 2006.
  20. Masuo Y. Effects of environmental stress on the rat brain: comparison with animal models for developmental disorders. Seminar in the Department of Psychiatry, Fuculty of Medicine, Universite Louis Pasteur, Strasbourg, France, Feb. 17, 2006.
  21. Masuo Y. Effects of environmental stress on the rat brain: comparison with animal models for developmental disorders. Seminar in the Maison Universitaire France-Japon, Strasbourg, France, Feb. 16, 2006.
  22. Masuo Y. Effects of environmental stress on the rat brain: comparison with rat models for attention-deficit hyperactivity disorder (ADHD). KU-AIST Joint Symposium on Stress Signaling and Monitoring, Seoul, Korea, Dec. 5, 2005.
  23. Masuo Y, Ishido M, Sawa H, Morita M, Nagashima K, Oka S, Niki E. Gene expression profile in rat models of attention-deficit hyperactivity disorder. World DNA and Genome Day, Dalian, China, April 25-29, 2005.
  24. Ishikawa Y, Kozakai T, Morita H, Saida K, Oka S, Masuo Y. Rapid detection of mycoplasma contamination in cell cultures by real-time PCR. 44th Annual Meeting of the American Society for Cell Biology, Washinton, D.C., U.S.A., Dec. 4-8, 2004.
  25. Ishido M, Masuo Y, Oka S, Niki E, Mortia M. An Environmental chemical reproduces the features seen in postencephalic lethargica of von Economo syndrome. 34th Annual Meeting of the Society for Neuroscience, San Diego, California, U.S.A., Oct. 23-27, 2004.
  26. Masuo Y, Ishido M, Sawa H, Morita M, Nagashima K, Oka S, Niki E. Analysis of rat models of hyperkinetic disorder. 34th Annual Meeting of the Society for Neuroscience, San Diego, California, U.S.A., Oct. 23-27, 2004.
  27. Masuo Y. Animal models for ADHD: the hyperactive rats. International symposium on “Autism and Related Developmental Disorders – Gene-environment interaction in the brain”, Tokyo, Oct. 16, 2004.
  28. Ishido M, Masuo Y, Kunimoto M, Oka S, Morita M. DNA array analyses of endocrine disruptor-caused gehavioral hyperactive rats. 33rd Annual Meeting of the Society for Neuroscience, New Orleans, U.S.A., Nov. 8-12, 2003.
  29. Masuo Y, Ishido M, Morita M, Oka S. Motor hyperactivity and gene expression in rats with neonatal 6-hydroxydopamine lesions. 33rd Annual Meeting of the Society for Neuroscience, New Orleans, U.S.A., Nov. 8-12, 2003.
  30. Ishido M, Morita M, Oka S, Masuo Y. Alterations by endocrine disruptors of gene expression of G-protein-coupled receptors in the rat brain, Symposium on GPCRs Satellite Symposium of the 6th International Symposium on VIP, PACAP and Related Peptides, Hakone, Japan, Sep. 4, 2003. Regul peptides. 115 (2003) 68.
  31.  Masuo Y, Oka S, Morita M, Ishido M. Physiological roles of PACAP in the central nervous system and endocrine disruptors. 6th International symposium on VIP, PACAP and Related Peptides, Hakone, Japan, Sep. 1–4, 2003.Oral presentation and Organizer: the Professor Noboru Yanaihara Memorial Session, Regul peptides. 115 (2003) 63.Program Committee
  32. Ishido M, Masuo Y, Oka S, Kunimoto M, Morita M. A new screening system for behavioral traits produced by endocrine disruptors. 32nd Annual Meeting of the Society for Neuroscience, Orlando, Florida, U.S.A., Nov. 2-7, 2002.
  33. Masuo Y, Ishido M, Morita M, Oka S. Gene expression profiling in the CNS of hyperkinetic child model rats. 32nd Annual Meeting of the Society for Neuroscience, Orlando, Florida, U.S.A., Nov. 2-7, 2002.
  34. Masuo Y, Ishikawa Y, Kozakai T, Uchide T, Saida K, Komatsu Y. Vasoactive intestinal contractor (VIC)/endothelin-2 gene expression in the murine CNS and effects of cold injury. 31st Annual Meeting of the Society for Neuroscience, San Diego, California, U.S.A., Nov. 10-15, 2001.
  35. Uchide T, Adur J, Kozakai T, Masuo Y, Sasaki T, Temma K, Saida K. Differential expression of endothelin-1 and vasoactive intestinal contractor genes in organs of developing mouse. 7th International Conference on Endothelin, Edinburgh, U.K., Sep. 16-19, 2001.
  36. Kozakai T, Hong Z, Sakate M, Masuo Y, Uchide T, Saida K. Effect of aging on gene expression rates of ET-1 and ET-2/VIC in ethanol-induced gastric mucosal injury of the mouse. 7th International Conference on Endothelin, Edinburgh, U.K., Sep. 16-19, 2001.
  37. Masuo Y, Masaki T, Hori K, Nomura M, Takamatsu K. Morphological, physiological and behavioral analyses in hippocalcin knockout mice. 11th International Symposium on Calcium-Binding Protein and Calcium Function in Health and Disease, Kazusa Academia Park, Chiba, Japan, Oct. 19-23, 1999.
  38. Masuo Y, Ohtaki T, Suzuki N, Matsumoto H, Masuda Y, Matsumoto Y, Tokito F, Fujino M. Identification and function of pituitary adenylate cyclase activating polypeptide (PACAP). 3rd International Congress of Neuroendocrinology, Budapest, Hungary, July 3-8, 1994. Neuroendocrinol, 60 Suppl. 1 (1994) 17.
  39. Brouard A, Pélaprat D, Vial M, Lhiaubet AM, Masuo Y, Rostène W. Neurotensin-induced facilitation of [3H]dopamine release in primary cultures of mesencephalic cells: effect of calcium channel blockers. 23rd Annual Meeting of the Society for Neuroscience, Washington, D.C., U.S.A, Nov. 7-12, 1993. Soc Neurosci Abstr. 19 (1993) 1173.
  40. Kitada C, Ohtaki T, Masuda Y, Masuo Y, Nomura H, Asami T, Matsumoto Y, Satou M, Fujino M. Design and synthesis of ETA receptor antagonists and study of ETA receptor distribution. 3rd International Conference on Endothelin, Houston, Texas, U.S.A., Feb. 15-17, 1993.
  41. Dauch P, Masuo Y, Vincent JP, Checler F. Tissue distribution, cerebral regionalization and ontogeny of endopeptidase 24.16 in murines. 3ème Forum Peptides et Protéines, Biarritz, France, Mar. 22-26, 1993.
  42. Checler F, Barelli H, Dauch P, Vincent B, Dive V, Beaudet A, Daniel EE, Fox-Threlkeld JET, Masuo Y, Vincent JP. Recent advances on endopeptidase-3.4.24.16. 646th Annual Meeting of the Biochemical Society, Leeds, England, U.K., Mar. 30-Apr. 2, 1993.
  43. Checler F, Barelli H, Beaudet A, Dauch P, Masuo Y, Vincent B, Vincent JP. Recentes donnees sur l'endopeptidase 24.16. 21ème Colloque de la Societe de Neuroendocrinologie Experimentale, Nancy, France, Sep. 23-25, 1992.
  44. Kitabgi P, De Nadai F, Labbe-Jullie C, Dubuc I, Nouel D, Costentin J, Masuo Y, Rostène W, Woulfe J, Lafortune L, Beaudet A, Fulcrand H, Doulut S, Rodriguez M, Martinez J. Functional and pharmacological aspects of central neuropeptidergic transmission mediated by neurotensin and neuromedin N. 18th Collegium Internationale Neuro-Psychopharmacologicum Congress, Nice, France, June 28-July 2, 1992.
  45. Masuo Y, Ohtaki T, Matsumoto H, Masuda Y, Suzuki N, Watanabe T, Tsuda M, Fujino M. Regional distributions of pituitary adenylate cyclase activating polypeptide (PACAP) and its binding sites in the rat central nervous system. 2nd Annual PACAP Symposium, Satellite symposium for the 21st annual meeting of the Society for Neuroscience, New Orleans, LA, U.S.A., Nov. 10, 1991. Regul Peptides. 37 (1992) 313.
  46. Checler F, Dauch P, Masuo Y, Vincent JP. Neurotensin and neuromedin N undergo distinct proteolytic inactivation in ventral tegmental area and nucleus accumbens. The Neurobiology of Neurotensin, 2nd International Conference on Neurotensin, Palm Beach, Florida, U.S.A., July 6-9, 1991.
  47. Rostène W, Brouard A, Dana C, Masuo Y, Agid F, Vial M, Lhiaubet AM, Pélaprat D. Interaction between neurotensin and dopamine in the brain. Morphofunctional and clinical evidence. The Neurobiology of Neurotensin, 2nd International Conference on Neurotensin, Palm Beach, Florida, U.S.A., July 6-9, 1991.
  48. Giscard-Dartevelle S, Jullienne A, Masuo Y, Rostène W, Bouizar Z. Calcitonin gene-related peptide and calcitonin receptors: effects of cerebral lesions in the rat nucleus accumbens and ventral tegmental area. NY Acad Sci, Calcitonin Gene-Related Peptide, Graz, Austria, July 28-31, 1991. Regul Peptides. 34 (1991) 96.
  49. Desnos C, Darchen F, Masuo Y, Rostène W, Scherman D. Dynamic properties of monoamine storage vesicles: pharmacological and physiological implications. Advances in the Biosciences, Presynaptic receptors and neuronal transporters, Satellite Symposium to the IUPHAR (International Union of Pharmacology) Congress, Rouen, France, June 26-29, 1990.
  50. Rostène W, Masuo Y, Scherman D, Herman JP, Pélaprat D. Neurotensin receptors on dopaminergic neurons: evidence on cell cultures and application for fetal tissue transplant visualization. 20th Annual Meeting of the Society for Neuroscience, St. Louis, Missouri, U.S.A., Oct. 28-Nov. 2, 1990. Soc Neurosci Abstr. 16 (1990) 1343.
  51. Montagne MN, Masuo Y, Dussaillant M, Sarrieau A, Lamberts SW, Rostène W. Modification de la densité des sites de liaison des récepteurs du VIP, da la neurotensine et de la dopamine au cours d'une hyperprolactinemie experimentale chez la ratte, auniveau du striatum et de l'hypophyse. 19ème Colloque de la Societé Française de Neuroendocrinologie Experimentale, Reunion Franco-Canadienne, Rouen, France, Sep. 12-15, 1989.
  52. Scherman D, Masuo Y, Darchen F, Rostène W. Brain monoaminergic autoradiography using [3H]dihydrotetrabenazine and [125I]aminoketanserin binding to the vesicular monoamine transporter. 12th Meeting of the International Society for Neurochemistry, Algarve, Portugal, Apr. 23-28, 1989. J Neurochem. 52 Suppl. (1989) S81.
  53. Montagne MN, Masuo Y, Dussaillant M, Sarrieau A, Lamberts SW, Rostène W. Effets d'une hyperprolactinemie experimentale sur les récepteurs striataux du VIP, de la neurotensine et de la dopamine chez le rat. Societé Française des Neurosciences, 3ème Colloque National, Montpellier, France, May 9-12, 1989.
  54. Darchen F, Masuo Y, Vial M, Rostène W, Scherman D. Autoradiographie monoaminergique cérébrale par la [3H]dihydrotétrabénazine et la [125I]aminokétansérine, ligands du transporteur vésiculaire des monoamines. Societé Française des Neurosciences, 3ème Colloque Natinal, Montpellier, France, May 9-12, 1989.
  55. Masuo Y, Montagne MN, Pélaprat D, Scherman D, Rostène W. Regulations of neurotensin-containing neurons in the ventral tegmental area, substantia nigra and striatum. 9th European Winter Conference of Brain Research, Les Arc 200, France, Mar. 4-11, 1989.
  56. Rostène W, Dana C, Montagne MN, Masuo Y, Sarrieau A, Rosselin G, Kitabgi P, Beaudet A. Receptors for neurodigestive peptides in brain visualized and quantified by in vitro autoradiography. Beijing International Conference on Brain-Gut Peptides, Beijing, People's Republic of China, Nov. 6-8, 1988.
  57. Masuo Y, Rostène W. Changes in neurotensin binding site densities and endogenous contents in rat models of Parkinson's and Huntington's diseases. 7th International Symposium on Gastrointestinal Hormones, Shizuoka, Japan, Nov. 1-4, 1988. Biomed Res, 9 Suppl. 1 (1988) 166.
  58. Rostène W, Dana C, Masuo Y, Agid F, Hervé D, Tassin JP, Beaudet A, Kitabgi P. Recepteurs de la neurotensine: interaction avec les systemes dopaminergiques et leur implication dans la maladie de Parkinson et de Huntington. Colloque SERVIER Cannes, Les Neurotransmitteurs et Leurs Interférences: Implications en Neuro et Psychopathologie, Cannes, France, Mar. 4-6, 1988.
  59. Rostène W, Dubois A, Masuo Y, Agid F, Kitabgi P, Scatton B. Changes in neurotensin receptor density in Parkinson and Huntington brains. 8th European Winter Conference of Brain Research, Tignes, France, Mar. 1988.

Domestic meeting

110 presentations